Lilly’s decision to offer vials has also been seen as its way to combat the rise in compounding. Patients have been turning ...

We recently compiled a list of the Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks. In this article, we are ...

Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...

Stock markets moved in different directions Tuesday with traders' attention fixed on President-elect Donald Trump's tariff ...

Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...

Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...

The Golden Globes have a reputation for being Hollywood’s least serious awards show, allowing us all to revel in the mess.

DOVBLERON® was approved by China’s National Medical Products Administration (NMPA): 1) for the treatment of adult patients with locally advanced or metastatic ROS1-positive NSCLC who have previously ...

Robert F. Kennedy Jr.’s stated desire to ban drug commercials from TV seems unlikely to become reality, according to advertising experts, but even pressure from Washington that falls short of an ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other healthcare stocks Jim Cramer has made bold predictions about. Healthcare has been ...

Clean Science and Technology: The company’s arm Clean Fino-Chem has commenced commercial production of 2,5 ... Lupin: The company announced the acquisition of Huminsulin in India from Eli Lilly and ...